Deals Shaping the Medical Industry (11/2009)
Executive Summary
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
You may also be interested in...
Pfizer Oncology Pipeline Shows Pivot To Targeted Therapies
Pfizer was heavily invested in immuno-oncology combinations five years ago, but following setbacks, the pipeline has shifted considerably, shaped partly by the acquisition of Array.
Could A COVID-19 Vaccine Gain EUA Without Sponsor Cooperation?
The possibility, which seems driven by the culture of the times, may be legally possible, but experts raised many practical concerns.
There’s No Need To Include Off-Label Use In Labeling, FDA Says In Proposed Rule
After concerns from the medtech industry that a 2017 final rule requires sponsors with knowledge of off-label use of their product to add it to their label, the US FDA is proposing to delete the confusing text.
Need a specific report? 1000+ reports available Buy Reports